Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Critical Path Still Critical, But Delayed By Drug Safety Agenda – FDA

This article was originally published in The Gray Sheet

Executive Summary

Greater investments in tracking drug safety issues could continue to slow the implementation timeline for FDA's Critical Path initiative

You may also be interested in...



Critical Path Will Lead To Device Research Opportunities In ’06 – Woodcock

A formal Critical Path priority list to be released in the coming year will include device-focused initiatives, assured FDA Deputy Commissioner for Operations Janet Woodcock

Critical Path Will Lead To Device Research Opportunities In ’06 – Woodcock

A formal Critical Path priority list to be released in the coming year will include device-focused initiatives, assured FDA Deputy Commissioner for Operations Janet Woodcock

Devices Paroled, Not Unconditionally, From Hill’s Drug Safety Hearings

House Energy & Commerce and Senate HELP staffers differ slightly in their perceptions of medical device applicability to drug safety concerns, which are the preeminent FDA issue for the 109th Congress

UsernamePublicRestriction

Register

MT021594

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel